Lisinopril and Hydrochlorothiazide
- Product NDC
- 71610-838
- 11-digit product format
- 716100838
- Labeler code
- 71610
- Product ID
- 71610-838_1a04bf5f-b08a-02b4-e063-6294a90ac472
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA077912
- Marketing category
- ANDA
- Marketing start
- 2006-10-04
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 12.5; 20 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
| E7199S1YWR | LISINOPRIL | 83915-83-7 | LISINOPRIL |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-838-30 | 71610083830 | 30 TABLET in 1 BOTTLE (71610-838-30) | 30 tablet | 2024-05-31 | No | No | Historical |
| 71610-838-53 | 71610083853 | 60 TABLET in 1 BOTTLE (71610-838-53) | 60 tablet | 2024-05-31 | No | No | Historical |
| 71610-838-60 | 71610083860 | 90 TABLET in 1 BOTTLE (71610-838-60) | 90 tablet | 2024-05-31 | No | No | Historical |
| 71610-838-70 | 71610083870 | 120 TABLET in 1 BOTTLE (71610-838-70) | 120 tablet | 2024-05-31 | No | No | Historical |
| 71610-838-80 | 71610083880 | 180 TABLET in 1 BOTTLE (71610-838-80) | 180 tablet | 2024-05-31 | No | No | Historical |